High-Frequency rTMS Over the DLPFC for Chronic Low Back Pain
RTMS-CLBP
High-Frequency Repetitive Transcranial Magnetic Stimulation Over the Dorsolateral Prefrontal Cortex Enhances IL-10 and Reduces Pain in Chronic Low Back Pain: A Randomized Controlled Trial
2 other identifiers
interventional
30
1 country
1
Brief Summary
Neuropathic pain is a chronic condition that significantly affects quality of life and often responds poorly to conventional pharmacological treatments. Repetitive transcranial magnetic stimulation (rTMS) has emerged as a non-invasive neuromodulation technique with potential analgesic effects. This study aimed to evaluate the effectiveness of rTMS in reducing neuropathic pain intensity among patients with confirmed neuropathic pain. A clinical study was conducted involving adult patients who met diagnostic criteria for neuropathic pain. Participants received rTMS sessions targeting the motor cortex over a defined treatment period. Pain intensity was assessed using standardized pain scales before and after treatment. The study examined changes in pain scores following rTMS therapy and evaluated its potential as an adjunctive treatment for neuropathic pain. The findings of this study may contribute to understanding the therapeutic role of rTMS in the management of neuropathic pain and support its use as a non-invasive treatment option.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 9, 2026
CompletedFirst Posted
Study publicly available on registry
March 13, 2026
CompletedMarch 13, 2026
March 1, 2026
11 months
March 9, 2026
March 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain intensity score
Change in neuropathic pain intensity measured using the Visual Analog Scale (VAS). Pain scores are assessed before the rTMS intervention and after completion of the treatment sessions.
Baseline and immediately after completion of the rTMS treatment sessions
Study Arms (1)
rTMS Treatment
EXPERIMENTALParticipants receive repetitive transcranial magnetic stimulation (rTMS) applied over the primary motor cortex as a therapeutic intervention for neuropathic pain. Clinical outcomes including pain severity and inflammatory biomarkers are assessed before and after the intervention.
Interventions
Repetitive transcranial magnetic stimulation (rTMS) delivered over the primary motor cortex using a magnetic coil to generate repeated magnetic pulses. The stimulation sessions are administered to modulate cortical excitability and reduce neuropathic pain symptoms. Participants receive multiple treatment sessions according to the study protocol, and clinical outcomes are evaluated before and after the intervention.
Eligibility Criteria
You may qualify if:
- Adults aged 18-65 years
- Diagnosed with schizophrenia according to DSM-5 criteria
- Experiencing neuropathic pain or chronic pain symptoms
- Stable psychiatric medication for at least 4 weeks prior to enrollment
- Able to provide written informed consent
You may not qualify if:
- History of epilepsy or seizure disorders
- Presence of metallic implants in the head
- Severe neurological disorders
- Substance abuse within the past 6 months
- Pregnancy or breastfeeding
- Contraindications to rTMS therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hasanuddin University
Makassar, South Sulawesi, 90245, Indonesia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Neurologist
Study Record Dates
First Submitted
March 9, 2026
First Posted
March 13, 2026
Study Start
January 1, 2024
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
March 13, 2026
Record last verified: 2026-03